Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
05/08/2026 13:17
BRIEF-Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand Aug 5 (Reuters) -
ENTRADA THERAPEUTICS, INC. Q2 COLLABORATION REVENUE USD 898 THOUSAND
ENTRADA THERAPEUTICS, INC. Q2 OPERATING EXPENSES USD 45.861 MILLION
ENTRADA THERAPEUTICS, INC. Q2 INCOME FROM OPERATIONS USD -44.963 MILLION
Source text: ID:nGNX2h0KKY
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview